Get started
Author

Soumyajeet Paul

ORCID: 0000-0001-7982-2426
Observed ORCID: 0000-0001-7982-2426
OpenAlex ID: A5032392755
Bioisosterism in Drug Discovery and Development - An Overview
2022 · B.S. Jayashree, P. Sai Nikhil, et al. · Medicinal Chemistry · 62
NF-κB Regulation by Gut Microbiota Decides Homeostasis or Disease Outcome During Ageing
2022 · Shuning Zhang, Soumyajeet Paul, et al. · Frontiers in Cell and Developmental Biology · 40
PDF
Calixarenes and their Relevance in Anticancer Drug Development
2023 · Soumyajeet Paul, Ramaiah Selladurai Jeyaprakash, et al. · Medicinal Chemistry · 8
Metformin use and its association with various outcomes in COVID-19 patients with diabetes mellitus: a retrospective cohort study in a tertiary care facility
2024 · Muhilvannan Somasundaram, Sanjay Kurian Mathew, et al. · Annals of Medicine · 3
PDF
Development of a multivariable prediction model to assess potential drug-drug interactions in chronic kidney disease patients
2024 · Soumyajeet Paul, Ananya Rudra, et al. · Journal of Applied Pharmaceutical Science · 1
PDF
Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing
2026 · Asha K Rajan, Maria Ioana Onofrei, et al. · Figshare
Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing
2026 · Asha K Rajan, Maria Ioana Onofrei, et al. · Postgraduate Medicine
PDF
Works count: 8
Citation count: 114
H-index: 3
I10-index: 2
Year
Topic
Type